Navigation Links
HUYA Bioscience Int'l Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
Date:4/14/2008

FDA feedback validates HUYA's Integrated Co-Development Model for

China-sourced Drug Candidates

SAN DIEGO, April 14 /PRNewswire/ -- HUYA Bioscience International (HUYA), the leader in U.S./China pharmaceutical co-development, today announced the outcome of the first pre-IND (Investigational New Drug) consultation with the U.S. FDA for a development-stage compound sourced from China. The new compound, HBI-8000 (CS055 / Chidamide), licensed from Chipscreen Biosciences, Ltd. of Shenzhen, China, shows promise for the treatment of a broad range of cancers and is nearing completion of a Phase I trial in China. HUYA holds exclusive development and commercialization rights to the compound worldwide outside of China, while Chipscreen maintains rights in China.

HUYA received positive pre-IND comments from the FDA Oncology Division. HUYA's IND-enabling nonclinical development plan and proposed U.S. Phase I clinical plan were acceptable to the agency. In addition, the FDA indicated its willingness to accept both preclinical and clinical data generated in China as supportive information for the opening of a U.S. IND and initiation of a Phase I trial. HUYA is on track to file an IND application for HBI-8000 in the second half of 2008.

According to Mireille Gingras, Ph.D., CEO of HUYA, "The acceptance of Chinese data as supportive for our U.S. IND and Phase I plans is tremendous validation of our Integrated Co-Development Model. The ability to leverage data from China lowers risk and streamlines the clinical development process in the West. The outcome of this pre-IND consultation validates HUYA's leadership in Sino/American pharmaceutical co-development."

HBI-8000 is an orally bioavailable histone deacetylase (HDAC) inhibitor derived from the benzamide class. Histone deacetylase inhibitors are a new class of cancer drugs that induce selective regulation of gene expression in cancer cells. HBI-8000 has exhibited activity
'/>"/>

SOURCE HUYA Bioscience International
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
2. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
3. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
4. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
5. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
6. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
7. On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
8. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
9. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
10. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
11. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Sanofi Pasteur, the vaccines ... that it has entered into an exclusive, ... and commercialize its prophylactic vaccine against ... or MRSA. MRSA are responsible for ... to as multidrug-resistant Staphylococcus aureus ...
(Date:12/16/2009)... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a ... today announced top-line efficacy and safety results from ... the treatment of Peyronie,s disease. Peyronie,s disease is ... the shaft of the penis, which can distort ... impossible in advanced cases. The Phase 2b study, ...
(Date:12/16/2009)... WOONSOCKET, R.I., Dec. 16 CVS/pharmacy and ... stores are now offering H1N1 vaccine in 20 ... locations priority restrictions for receiving H1N1 vaccines continue, ... to be eligible to receive the shot while ... has been restocked and is available at MinuteClinic ...
Breaking Medicine Technology:Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 2Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 4BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 2BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 3BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 4CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 3CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 4Atrial fibrillation in endurance athletes still poses problems for sports cardiologists 49549 1Atrial fibrillation in endurance athletes still poses problems for sports cardiologists 49549 2Atrial fibrillation in endurance athletes still poses problems for sports cardiologists 49549 3METTLER TOLEDO Introduces an Affordable Reaction Block for Solid Phase Peptide Synthesis 28SPPS 29 12714 1METTLER TOLEDO Introduces an Affordable Reaction Block for Solid Phase Peptide Synthesis 28SPPS 29 12714 2Does Location Affect Kids Weight 3F 49542 1Does Location Affect Kids Weight 3F 49542 2
... a study published in The American Journal of ... Clinic psychiatrist Mark Frye, M.D., attempted to identify what ... to experience treatment-emergent mania (TEM).Bipolar disorder, also known as ... mood instability that can be serious and disabling. The ...
... for Type 2 Diabetes-PLYMOUTH MEETING, Pa., Feb. 10 ... promising preliminary Phase 1b clinical data for trodusquemine (MSI-1436), ... lead drug candidate for the treatment of type 2 ... CEO of Genaera, presented data from the first of ...
Other Medicine Technology:Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder 2Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder 3Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436) 2Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436) 3
(Date:12/17/2009)... 17 Researchers from the School of ... in the UK are today,encouraging families worldwide ... Year following concerning research* that shows two-thirds of ... a family (68%), with the,Portuguese being the least ... together. , According to ...
(Date:12/17/2009)... over the past three years and what has driven these changes ... ... Morehead, the human capital research firm, will host a webinar titled ... free hour-long webinar will be broadcast on Wednesday, January 27, 2010 ... Morehead’s SVP, Consulting Services and Trevor Byrd, Ph.D., a Morehead Consultant, ...
(Date:12/17/2009)... Healthcare Cost/Risk Analysis reports, activity measures and outcomes reporting to ... toward reduced claim costs and positive return on investment over ... ... Jacksonville, FL (PRWEB) December 17, 2009 -- ... in clinical/claims based cost risk analysis along with personalized nurse ...
(Date:12/16/2009)... -- If proposed health care legislation is enacted, ... insurance system. Approximately 18.4 million Californians and 161 ... upon employer-based insurance for their health care coverage. ... reform legislation entail specific requirements for employer-based insurance. ... for firms that currently comply with most new ...
(Date:12/16/2009)... Annual Gala Raises Significant Funds to Benefit of Children ... Christine Taylor, Gary Cole and Zachary Levi Join ... ,, LOS ANGELES, Dec. 16 At its ... three remarkable individuals. Hasbro President & CEO ... Award in recognition of his far-reaching philanthropic leadership ...
Breaking Medicine News(10 mins):Health News:The Family Walk - a Dying Tradition Around the World? 2Health News:Morehead Presents Webinar on "The State of Employee Engagement: A Year in Review" 2Health News:Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 2Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 4Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 5
... Light of New Evidence Showing the,Benefits of UV ... Today, the Indoor,Tanning Association (ITA) launched an ... and criticizing,dermatologists and the sunscreen and cosmetics industries ... advertising blitz begins with a full-page print ad ...
... Md. (March 26, 2008) -- The American Physiological Society ... the 2008 Henry Pickering Bowditch Memorial Award for early-career ... 42 years whose accomplishments are both original and outstanding. ... a professor of pharmacology and toxicology, has focused her ...
... Visiprise, Inc., a leader in,manufacturing execution systems (MES) ... named to START-IT magazine,s START-IT 125 list., ... editors and editorial advisors,of START-IT magazine to recognize ... market., Visiprise,s flagship solution, Visiprise Manufacturing, is ...
... Needed, Experts Say, PHILADELPHIA, March 26 ... group of healthcare leaders based at the,University of ... convene a,special conference to address the national shortage ... cannot be maintained, let alone,expanded, unless we educate ...
... 26 WPCS International,Incorporated (Nasdaq: WPCS ... specialty communication systems and wireless infrastructure, has,announced ... awarded approximately,$12 million in new contracts., ... for The University of,Connecticut, The Mashantucket Pequot ...
... ... BIG HORN, Wyo., March 26 Gourmetceuticals, LLC, ... for use in foods and beverages, today announced ... booster, and,PPL-240, an antioxidant, will be presented at ...
Other Medicine News:Health News:Indoor Tanning Association Launches Campaign Attacking Melanoma Hype 2Health News:MSU professor earns Bowditch Award for work on hypertension 2Health News:MSU professor earns Bowditch Award for work on hypertension 3Health News:Visiprise Named One of the Top Manufacturing Technology Providers 2Health News:Council Calls on White House to Convene Conference on Physician and Nurse Supply 2Health News:WPCS Announces $12 Million in New Projects 2Health News:Gourmetceuticals to Present Data from Four Studies at Experimental Biology 2008 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: